Gagliano A, Puligheddu M, Ronzano N, Congiu P, Tanca M, Cursio I
Nat Sci Sleep. 2021; 13:1209-1224.
PMID: 34326674
PMC: 8315772.
DOI: 10.2147/NSS.S300818.
Mondello S, Kobeissy F, Mechref Y, Zhao J, El Hayek S, Zibara K
Nat Sci Sleep. 2021; 13:873-883.
PMID: 34234594
PMC: 8243594.
DOI: 10.2147/NSS.S311801.
McCall C, Winkelman J
J Clin Sleep Med. 2018; 14(9):1569-1576.
PMID: 30176966
PMC: 6134249.
DOI: 10.5664/jcsm.7338.
Zhang R, Brandt M, Schrempf W, Beste C, Stock A
Neuroimage Clin. 2017; 15:644-652.
PMID: 28664035
PMC: 5480014.
DOI: 10.1016/j.nicl.2017.06.018.
Rizzo G, Li X, Galantucci S, Filippi M, Cho Y
Sleep Med. 2016; 31:39-48.
PMID: 27838239
PMC: 5846689.
DOI: 10.1016/j.sleep.2016.07.018.
Longitudinal relationships of periodic limb movements during sleep and incident atrial fibrillation.
May A, Blackwell T, Stone K, Cawthon P, Sauer W, Varosy P
Sleep Med. 2016; 25:78-86.
PMID: 27823721
PMC: 5126983.
DOI: 10.1016/j.sleep.2016.08.009.
DTI and VBM reveal white matter changes without associated gray matter changes in patients with idiopathic restless legs syndrome.
Belke M, Heverhagen J, Keil B, Rosenow F, Oertel W, Stiasny-Kolster K
Brain Behav. 2015; 5(9):e00327.
PMID: 26442748
PMC: 4589804.
DOI: 10.1002/brb3.327.
Imaging brain functional and metabolic changes in restless legs syndrome.
Rizzo G, Tonon C, Manners D, Testa C, Lodi R
Curr Neurol Neurosci Rep. 2013; 13(9):372.
PMID: 23881621
DOI: 10.1007/s11910-013-0372-1.
Increased synaptic dopamine in the putamen in restless legs syndrome.
Earley C, Kuwabara H, Wong D, Gamaldo C, Salas R, Brasic J
Sleep. 2013; 36(1):51-7.
PMID: 23288971
PMC: 3524542.
DOI: 10.5665/sleep.2300.
Periodic leg movements in sleep in elderly patients with Parkinsonism and Alzheimer's disease.
Bliwise D, Trotti L, Yesavage J, Rye D
Eur J Neurol. 2012; 19(6):918-23.
PMID: 22340757
PMC: 3351548.
DOI: 10.1111/j.1468-1331.2012.03673.x.
Ropinirole in restless legs syndrome and periodic limb movement disorder.
Erichsen D, Ferri R, Gozal D
Ther Clin Risk Manag. 2010; 6:173-82.
PMID: 20421915
PMC: 2857615.
DOI: 10.2147/tcrm.s6717.
Neuroimaging insights into the pathophysiology of sleep disorders.
Desseilles M, Dang-Vu T, Schabus M, Sterpenich V, Maquet P, Schwartz S
Sleep. 2008; 31(6):777-94.
PMID: 18548822
PMC: 2442420.
DOI: 10.1093/sleep/31.6.777.
Restless legs syndrome: pathophysiology, diagnosis and treatment.
Satija P, Ondo W
CNS Drugs. 2008; 22(6):497-518.
PMID: 18484792
DOI: 10.2165/00023210-200822060-00004.
REM sleep characteristics in narcolepsy and REM sleep behavior disorder.
Dauvilliers Y, Rompre S, Gagnon J, Vendette M, Petit D, Montplaisir J
Sleep. 2007; 30(7):844-9.
PMID: 17682654
PMC: 1978363.
DOI: 10.1093/sleep/30.7.844.
[Neurophysiological and neuroimaging studies for restless legs syndrome and periodic leg movement disorder].
Happe S, Paulus W
Nervenarzt. 2005; 77(6):652, 654-6, 659-62.
PMID: 16341734
DOI: 10.1007/s00115-005-2025-3.
Apomorphine in idiopathic restless legs syndrome: an exploratory study.
Tribl G, Sycha T, Kotzailias N, Zeitlhofer J, Auff E
J Neurol Neurosurg Psychiatry. 2005; 76(2):181-5.
PMID: 15654028
PMC: 1739522.
DOI: 10.1136/jnnp.2003.034843.
Sleep-related non epileptic motor disorders.
Montagna P
J Neurol. 2004; 251(7):781-94.
PMID: 15258779
DOI: 10.1007/s00415-004-0478-0.
Role of dopamine receptor agonists in the treatment of restless legs syndrome.
Happe S, Trenkwalder C
CNS Drugs. 2004; 18(1):27-36.
PMID: 14731057
DOI: 10.2165/00023210-200418010-00003.
Pergolide: treatment of choice in restless legs syndrome (RLS) and nocturnal myoclonus syndrome (NMS). A double-blind randomized crossover trial of pergolide versus L-Dopa.
Staedt J, Wassmuth F, Ziemann U, Hajak G, Ruther E, Stoppe G
J Neural Transm (Vienna). 1997; 104(4-5):461-8.
PMID: 9295178
DOI: 10.1007/BF01277664.
Restless legs and periodic leg movements in sleep syndromes.
Wetter T, Pollmacher T
J Neurol. 1997; 244(4 Suppl 1):S37-45.
PMID: 9112588
DOI: 10.1007/BF03160570.